Ending the world’s diabetes epidemic could be one step closer, with a promising new technique curing the condition in mice.
Scientists at the University of Texas announced the breakthrough, which uses a novel approach that may eliminate Type 1 diabetes and see painful insulin injections become a thing of the past.
University of Texas Health Science Center doctors used a virus as a carrier to introduce insulin-producing genes into the pancreas of rodent. (read more)
Treatment with the insulin degludec compared to glargine U100 for 32 weeks resulted in a reduced rate of hypoglycemic (low blood sugar) episodes among patients with type 1 or 2 diabetes and at least one risk factor for hypoglycemia, according to two studies published by JAMA.
In one study, Wendy Lane, M.D., of Mountain Diabetes and Endocrine Center, Asheville, N.C., and colleagues randomly assigned 501 adults with type 1 diabetes and at least one hypoglycemia risk factor to receive once-daily insulin degludec followed by insulin glargine U100 (n = 249) or to receive insulin glargine U100 followed by insulin degludec (n = 252) for two 32-week treatment periods. The patients were randomized to morning or evening dosing within each treatment sequence. (read more)
Healthcare providers are being urged to warn people that an insulin cartridge holder used in a number of pens has been found to be faulty.
Novo Nordisk, the company which makes the recalled product, said the warning applies to the NovoPen® Echo® and NovoPen®5.
It is thought some batches could crack or break if exposed to certain chemicals, such as household cleaning agents, so people who use the products are being warned to contact Novo Nordisk directly for a replacement cartridge holder. (read more)